|
Volumn 322, Issue 7294, 2001, Pages 1087-1088
|
Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
DIDANOSINE;
EFAVIRENZ;
NELFINAVIR;
NEVIRAPINE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SAQUINAVIR;
ZALCITABINE;
ZIDOVUDINE;
ADULT;
ARTICLE;
CONTROLLED STUDY;
FEMALE;
GENE MUTATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE;
INFECTION PREVENTION;
MAJOR CLINICAL STUDY;
MALE;
PRIMARY INFECTION;
PRIORITY JOURNAL;
PUBLIC HEALTH;
RISK FACTOR;
UNITED KINGDOM;
VIRUS STRAIN;
VIRUS TRANSMISSION;
ADULT;
ANTI-HIV AGENTS;
DRUG RESISTANCE, MICROBIAL;
FEMALE;
HIV INFECTIONS;
HIV-1;
HUMANS;
MALE;
MUTATION;
PREVALENCE;
PROSPECTIVE STUDIES;
RETROSPECTIVE STUDIES;
|
EID: 0035810577
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (168)
|
References (8)
|